SCC VII cells and U87MG delta EGFR cells were seeded on 10 cm dishes in cell culture mediums and incubated in 37 °C under 5% CO2 incubator until 70~80% confluent. They were treated with boron compounds 1 (B1), 2 (B2), 4, or BPA in cell culture mediums for 4 h. The concentration of 10B in the medium was 0.35 or 0.7 ppm for B1 and B2, 0.48 ppm or 2.42 ppm for compound 4 and 20 ppm for BPA. A stock solution of 10B-para-boronophenylalanine (BPA) was used for all experiments. BPA was purchased from KatChem Ltd. (Prague, Czech Republic) and prepared by dissolving it in distributed water as a complex with 3% fructose for BPA. The 10B concentrations were measured by means of prompt gamma-ray spectrometry using a thermal neutron guide tube installed at the Kyoto University Research Reactor (KUR), and the value was about 1000 ± 4.55 ppm. To count the number of cells after treatment with the boron compounds, the cells (n = 1) were washed with PBS, detached by trypsin, and counted with a hemocytometer. For the measurement of boron uptake, the cells (n = 3) were washed with PBS (3 mL × 3) and digested with 60% HNO3 aq (1 mL) at room temperature for 24 h, which were transferred to 15 mL centrifuge tubes with Milli-Q water (4 mL). These tubes were centrifuged at 3000 rpm and 4 °C for 10 min, and the resulting sample solutions were filtered. The concentration of boron atoms was determined by ICP-OES (ICPE-9000, Shimadzu, Kyoto, Japan). All reagents were purchased from FUJIFILM Wako Pure Chemical Corporation (Osaka, Japan).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.